Mark Lebwohl

34PUBLICATIONS
71CO-AUTHORS
Disease surveillanceAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical parasitologyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 30, 2026
Treatment Patterns, Drug Survival, and Effectiveness of Tildrakizumab Among Patients with Prior Interleukin-17 Experience in the PPD CorEvitas Psoriasis Registry.

|Jul 20, 2026
Nonpruritic Eczematous Flares During Nemolizumab Therapy: A Case Series.

|Jun 02, 2026
Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.

|May 08, 2026
The Misdiagnosis of Pemphigus Foliaceus as Psoriasis.

|May 02, 2026
Real-World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens.

|Apr 11, 2026
Use of Oral JAK Inhibitors and a TYK2 Inhibitor in the Treatment of Psoriasis-Eczema Overlap (PsEma): A Retrospective Study.

Marley Cutrona, Sophie Guénin, Mindy Kresch-Vatch

Pageof 6

Frequent Collaborators

6 joint publications

Bruce Strober

4 joint publications

April W Armstrong

4 joint publications

Abby A Jacobson

4 joint publications

Emma Guttman-Yassky